Literature DB >> 12771546

Analysis of gene expression in peripheral blood eosinophils from patients with atopic dermatitis by differential display.

Ryoichi Hashida1, Kaoru Ogawa, Masami Miyagawa, Yuji Sugita, Eiki Takahashi, Takeshi Nagasu, Toshio Katsunuma, Akira Akasawa, Gozoh Tsujimoto, Kenji Matsumoto, Hirohisa Saito.   

Abstract

To identify the genes related to atopic dermatitis (AD), we compared gene expression in eosinophils from AD patients and healthy volunteers. RNA was prepared from peripheral blood eosinophils. Gene expression was monitored by fluorescent differential display (DD) and real-time RT-PCR. Eighteen new sequences, including expressed sequence tags (ESTs), were expressed at higher levels in eosinophils from AD patients than in those from healthy volunteers. The functions of most of these genes are unknown. We found no correlation between the expression of a particular gene and clinical markers such as the number of eosinophils and the amount of IgE. Multivariate analysis of the gene expression data in each sample showed a very high coefficient of correlation among the copy numbers of each gene. The genes under investigation were also expressed in cultured blood eosinophils after IL-4, IL-5 and IFN-gamma stimulation. We were able to predict the function of some of the sequences by scanning for homologies within either the human or mouse genome databases. The mouse counterpart of one of these genes, intersectin 2, was expressed dramatically, as measured by ear edema, in 1-fluoro-2,4-dinitrobenzene-induced mouse contact dermatitis and in NC/Nga mouse dermatitis. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12771546     DOI: 10.1159/000070478

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  1 in total

Review 1.  The NR4A nuclear receptor family in eosinophils.

Authors:  Ryoichi Hashida; Naganari Ohkura; Hirohisa Saito; Gozoh Tsujimoto
Journal:  J Hum Genet       Date:  2006-11-10       Impact factor: 3.172

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.